30 November 2018 : Laboratory Research
Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
DOI: 10.12659/MSM.911394
Med Sci Monit 2018; 24: LBR8669-8677
HTML version available soon